Release Date: 04/11/16 19:27 Summary: ASX Listing Rules Waiver Price Sensitive: No Download Document 48.13KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%